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Abstract
Introduction The rate of weaning of vasopressors drugs is
usually an empirical choice made by the treating in critically ill
patients. We applied fuzzy logic principles to modify intravenous
norepinephrine (noradrenaline) infusion rates during
norepinephrine infusion in septic patients in order to reduce the
duration of shock.
Methods Septic patients were randomly assigned to
norepinephrine infused either at the clinician's discretion
(control group) or under closed-loop control based on fuzzy
logic (fuzzy group). The infusion rate changed automatically after
analysis of mean arterial pressure in the fuzzy group. The primary
end-point was time to cessation of norepinephrine. The
secondary end-points were 28-day survival, total amount of
norepinephine infused and duration of mechanical ventilation.
Results Nineteen patients were randomly assigned to fuzzy
group and 20 to control group. Weaning of norepinephrine was
achieved in 18 of the 20 control patients and in all 19 fuzzy
group patients. Median (interquartile range) duration of shock
was significantly shorter in the fuzzy group than in the control
group (28.5 [20.5 to 42] hours versus 57.5 [43.7 to 117.5]
hours;  P  < 0.0001). There was no significant difference in
duration of mechanical ventilation or survival at 28 days between
the two groups. The median (interquartile range) total amount of
norepinephrine infused during shock was significantly lower in
the fuzzy group than in the control group (0.6 [0.2 to 1.0] μg/kg
versus 1.4 [0.6 to 2.7] μg/kg; P < 0.01).
Conclusions Our study has shown a reduction in
norepinephrine weaning duration in septic patients enrolled in
the fuzzy group. We attribute this reduction to fuzzy control of
norepinephrine infusion.
Trial registration Trial registration: Clinicaltrials.gov
NCT00763906.
Introduction
Despite advances in critical care, the death rate from severe
sepsis remains approximately 30% to 50%. In 1995, severe
sepsis accounted for 9.3% of all deaths in the USA [1]. It is
generally agreed that fluid resuscitation and vasopressors
should be initiated promptly to treat shock and organ failure,
and rapidly restore the mean arterial pressure (MAP) to 60 to
90 mmHg [2,3].
The vasopressor in most common use is norepinephrine
(noradrenaline) but, because of its weak inotropic effect and
concerns about regional blood flow, dobutamine is often
administered concomitantly. As soon as haemodynamic varia-
ICU: intensive care unit; MAP: mean arterial pressure.Critical Care    Vol 12 No 6    Merouani et al.
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bles are stable, vasopressor and inotropic support is gradually
weaned in order to decrease duration of shock and avoid
adrenoreceptor downregulation and catecholamine refractori-
ness [4]. However, there is little published evidence on how to
wean support. The weaning rate is usually chosen empirically
because conventional quantitative models cannot cope with
the complexity of the biological systems involved.
Closed-loop control based on fuzzy logic permits the use of
conventional symbolic systems (specified in the form of tabu-
lated rules) in continuous form and can ensure stability
through adaptive self-organizing control. It has been applied to
supervisory control in several medical fields [5]. For instance,
a multiple drug haemodynamic supervisory control system has
been developed for controlling MAP and cardiac output [6].
However, to our knowledge, there are very few randomized
controlled trials comparing fuzzy logic decisions with human
decisions by practitioners [7,8].
We compared, in a prospective, randomized pilot study, the
duration of weaning of norepinephrine as determined by a
closed-loop control based on fuzzy logic algorithm versus
manual control by the clinician in patients with septic shock.
Our goal was to reduce the duration of poorly controlled
haemodynamic status by using a closed-loop controller based
on fuzzy logic in septic patients.
Materials and methods
Approval of study design and informed consent
This prospective, randomized controlled trial was conducted
in the 16-bed intensive care unit (ICU) of Avicenne University
Hospital. The study was approved by the Consultative Council
for the Protection of Persons Volunteering for Biomedical
Research of Aulnay Hospital. Throughout the study the clinical
coordinating center (Association pour le Développement de la
Recherche et l'Enseignement de la Médecine d'Urgence
(ADREMU), Bobigny) was available 24 hours a day to answer
investigators' questions about patient eligibility and safety, and
to deal with any reported serious adverse events.
Requirement for informed consent was waived because
patients were under mechanical ventilation and sedated. How-
ever, written informed consent was obtained from patients'
authorized representatives upon entry into the study and from
the patients themselves for use of their individual data, as soon
as their clinical status made this possible.
Eligibility
Patients were enrolled consecutively from December 2004
through January 2006 and were eligible for entry into the study
if they had known or suspected infection according to clinical
criteria and if, within the previous 24 hours, they had mani-
fested three or more signs of a systemic inflammatory
response syndrome and sepsis-induced dysfunction of at
least one organ or system that lasted for less than 24 hours.
The criteria for severe sepsis were those defined by Bernard
and coworkers [9]. In addition, for inclusion, norepinephrine
infusion had to be begun within 24 hours before randomization
and had to have been in use for at least 6 hours but for less
than 24 hours. Exclusion criteria were age less than 18 years,
pregnancy, weight above 135 kg, requirement for continuous
epinephrine infusion, severe head injury, stroke and comatose
state after cardiac arrest.
Baseline characteristics including demographics, history and
type of infection, and laboratory test results were obtained
within the 24 hours before randomization. Disease severity at
baseline was assessed using the Simplified Acute Physiology
score II and the Sequential Organ Failure Assessment score
[10,11].
Treatment
Patients were randomly assigned to norepinephrine infused
either at the clinician's discretion or under closed-loop control
based on fuzzy logic. The method of randomization was a one-
to-one allocation. The target MAP was 65 to 75 mmHg
(depending on the underlying condition of the patient), meas-
ured using a Siemens SC9000 monitor (Siemens, Amster-
dam, The Netherlands).
In the control group, the intensivist adapted norepinephrine
doses to the haemodynamic status of the patient. There was
no nurse norepinephrine weaning protocol in our ICU. In the
'fuzzy' group patients, the monitor was connected to a compu-
ter that converted the MAP and norepinephrine infusion rate
into fuzzy datasets and automatically calculated the required
change in rate of infusion. MAP control can be viewed in terms
of engineering control theory (Figure 1). MAP level and MAP
variation (ΔMAP) – the variables to be controlled – are the
inputs of the controlled system, whereas the norepinephrine
infusion rate is the output to be adjusted to achieve the
desired MAP value. The computer was in turn connected to an
automated syringe pump (Fresenius Vial Inc., Brezins, France).
Fuzzy set theory is summarized in the additional materials [see
Additional data file 1]. The infusion rate changed automatically
every 7 minutes after analysis of the MAP and the ΔMAP. It
could change by +1 to +20% (or -1% to -20%) without human
oversight. However, all changes in rate greater than 40% (two
consecutive changes of 20%) when the infusion rate of nore-
pinephrine was superior to 1 mg/hour had to be validated by
the clinician. When it occurred, an audible alarm sounded and
a member of the medical team was required to validate (or not)
the change proposed by the computer after patient assess-
ment. At any time, the intensivist could interrupt the computer
control and change the dosage manually if the patient's condi-
tion required it. A study manager (FA or MM) was available 24
hours per day and 7 days per week while any patient was
included in the study to give advice if an abnormality occurred.
Other safety control included the sounding of an alarm if the
computer was disconnected.Available online http://ccforum.com/content/12/6/R155
Page 3 of 8
(page number not for citation purposes)
In order to obtain an accurate MAP measurement with the
least possible number of artefacts (caused by flushes, bends,
knotting or blood sampling on the arterial lines), we measured
MAP every 10 seconds for 7 minutes and then processed all
obtained values with median values filtering. Moreover, this fil-
ter eliminated all artefact-predefined values. Thus, the MAP
regulated by the algorithm is calculated from a set of 42 values
of MAP. The reason for applying such a process to the data
obtained from arterial measures was to increase their resist-
ance to artefacts.
In order to avoid any modification concerning management of
enrolled patients, all intensivists were blinded to the end-point
definitions of our study (duration of norepinephrine weaning,
mortality and duration of mechanical ventilation). Only two
independent researchers (MM and FA) were permitted to per-
form adjustments to the computer. These investigators were
not directly involved in patient care.
Outcome measures
Upon inclusion, patients were followed throughout their ICU
stay after or until death. The following were recorded daily
while the patients were receiving norepinephrine in the ICU:
vital signs, standard laboratory variables, results for cultures of
specimens from new infection sites, and interventions. The pri-
mary end-point was duration of weaning, defined as cessation
of vasopressor support [12]. Vasopressor support was
defined as a norepinephrine dose above 0.1 mg/hour. The
secondary end-points were 28-day survival, total amount of
norepinephine infused, duration of mechanical ventilation and
length of stay in the ICU.
Statistical analysis
We hypothesized that closed-loop control of infusion would
reduce norepinephrine weaning time by 45%. We calculated
that we would require 20 patients per group to detect a 45%
reduction, assuming a 5% α error, a 10% β error and 90%
power. We used Kaplan-Meier curves to analyze probable
duration of vasopressor treatment, mechanical ventilation and
survival. To compare the two groups, we used the log-rank test
or competitive risk analysis when the occurrence of death
could interact with the event under study (for instance, the
event 'cessation of mechanical ventilation' may occur because
the patient no longer requires mechanical ventilation or
because he or she died) [13]. All of the tests were two-sided
at 5% significance levels. All calculations were made using
SAS 9.1.3 (SAS Institute, Cary, NC, USA).
Results
Baseline characteristics
We evaluated 42 patients. Three patients were removed from
the study; two patients were excluded because they did not
meet the eligibility criteria and one patient was excluded
because of a technical problem. The remaining 39 patients
were randomly assigned either to the fuzzy group (n = 19) or
to the control group (n = 20).
Demographics, disease severity, haemodynamic variables,
and the type and anatomical site of the underlying infection
were similar in the control and fuzzy groups (Table 1).
Four patients received dobutamine (no significant difference
between the two groups) and one patient received epine-
phrine after randomization. There was no difference in crystal-
loid/colloid infusion volumes during the period of shock
between the two groups.
End-points
Weaning of norepinephrine was achieved in 18 of the 20 con-
trol patients and in all 19 fuzzy group patients. Duration of
shock was significantly shorter (P < 0.001) in the fuzzy group
than in the control group (Figure 2). The median time of vaso-
pressor support was 28.5 hours (interquartile range = 20.5 to
42 hours) in the fuzzy group and 57.5 hours (interquartile
range = 43.7 to 117.5 hours) in the control group. Two control
group patients (5.1%) died before norepinephrine weaning
was completed (no significant difference between groups),
corresponding to the weaning failures. There was no signifi-
cant difference in duration of mechanical ventilation between
the two groups (Table 2). The total amount of norepinephrine
infused was significantly lower in the fuzzy group than in the
control group (Table 2).
Figure 1
Scheme for a fuzzy logic based norepinephrine controller Scheme for a fuzzy logic based norepinephrine controller. The monitor 
was connected to a computer that converted the mean arterial pres-
sure (MAP) and norepinephrine infusion rate into fuzzy datasets and 
automatically calculated the required change in rate of infusion. MAP 
level and MAP variation (ΔMAP) – the variables to be controlled – are 
the outputs of the controlled system, whereas the norepinephrine infu-
sion rate is the input to be adjusted to reach the desired MAP value. 
The infusion rate changed automatically every 7 minutes after analysis 
of the MAP and the ΔMAP.Critical Care    Vol 12 No 6    Merouani et al.
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Table 1
Baseline characteristics of the patients
Variable Control group (n = 20) Fuzzy group (n = 19)
Age (years) 66 ± 12 64 ± 12
Male sex 70% 58%
Weight (kg) 67 ± 15 71 ± 14
Prior or coexisting conditions
Chronic obstructive pulmonary disease 40% 37%
Congestive cardiomyopathy 0% 5%
Diabetes 10% 5%
Liver disease 2% 0%
Chronic renal failure 0% 0%
Cancer 30% 26%
Activity limitation (A/B/C/D)a 3/8/7/2 4/10/5/0
McCabe classification (1/2/3)b 10/6/4 12/4/3
Recent surgical history 20% 16%
Disease severity
Temperature (°C) 36.8 ± 1.8 37.7 ± 1.5
Heart rate (beats/minute) 119 ± 26 103 ± 27
Systolic blood pressure (mmHg) 84 ± 14 80 ± 22
Mean blood pressure (mmHg) 61 ± 12 59 ± 16
White cell count (/mm3) 16,100 ± 8,800 17,600 ± 12,000
Platelet (× 103/μl) 263 ± 198 262 ± 138
Haematocrit (%) 30 ± 7 32 ± 6
Blood urea nitrogen (mmol/l) 10.3 ± 6.3 10.4 ± 6.2
Creatinine (μmol/l) 113 ± 70 136 ± 88
Total bilirubin (μmol/l) 12.3 15.5
Lactate (mmol/l) 2.5 ± 2.1 2.0 ± 0.8
PaO2/FiO2 (mmHg) 166 ± 81 181 ± 93
Arterial pH 7.28 ± 0.14 7.31 ± 0.09
SAPS II scale 62 ± 23 58 ± 16
Initial SOFA score 11.0 ± 2.5 11.2 ± 3.3
Norepinephrine infusion at the time of randomization (μg/kg per minute) 0.6 ± 0.4 0.8 ± 0.4
Site of infectionc
Lung 75% 63%
Abdomen 25% 10%
Urinary tract 5% 15%
Other 5% 10%
Bacterial pathogen staining
Gram-negative 40% 58%
Gram-positive 25% 10%
Unconfirmed 35% 32%
Values are expressed as number, percentage or mean ± standard deviation. Percentages may not total 100 because of rounding. aLevels of 
activity were defined as follows (Knaus Chronic Health Status score): A = prior good health, no functional limitations; B = mild to moderate 
limitation of activity because of a chronic medical problem; C = chronic disease producing serious but not incapacitating limitation of activity; and 
D = severe restriction of activity due to disease, includes persons bedridden or institutionalized due to illness. bMcCabe classification: 1 = 
nonfatal disease; 2 = ultimately fatal disease; and 3 = rapidly fatal disease. cThe site of infection was either documented or presumed on the basis 
of clinical findings. PaO2/FiO2, arterial oxygen tension/fractional inspuired oxygen ratio; SAPS, Simplified Acute Physiology Score; SOFA, 
Sequential Organ Failure Assessment.Available online http://ccforum.com/content/12/6/R155
Page 5 of 8
(page number not for citation purposes)
Twenty-eight days after inclusion, seven out of 19 patients in
the fuzzy group (37%) and seven out of 20 (35%) of the
patients in the control group had died. The difference between
groups in the rate of death from any cause was not significant.
A Kaplan-Meier analysis of survival yielded similar results.
Figure 3 illustrates the changes in norepinephrine infusion rate
for one patient from each group. Whereas there is a linear
decrease in rate in the control group patient, the change is
more or less sinusoidal in the fuzzy group patient.
Discussion
Our study demonstrates a large and significant reduction in
time of cessation of norepinephrine in patients enrolled in the
group undergoing closed-loop control based on fuzzy logic.
We attribute this reduction to closed-loop control of norepine-
phrine infusions. Moreover, the total amount of norepinephrine
infused was significantly lower in the fuzzy group than in the
control group. However, the reduced duration of shock was
not associated with an expected reduction in mortality or in the
duration of mechanical ventilation, perhaps because of the
small numbers of patients included in the study.
Modern medicine is faced with the challenge of acquiring, ana-
lyzing and applying the large amount of knowledge necessary
to solve complex clinical problems [14]. This pilot study sup-
ports the view that closed-loop control of norepinephrine
administration is safe and feasible in intensive care. Currently,
fuzzy logic, neural networks and genetic algorithms are three
popular artificial intelligence techniques that are widely used in
many medical applications [15]. Fuzzy logic is the science of
reasoning, thinking and inference that recognizes and exploits
real-world phenomenon that everything is a matter of degree.
Instead of assuming that everything is black or white (conven-
tional logic), fuzzy logic recognizes that in reality most things
fall somewhere in between (that is, varying shades of grey)
[14]. It was introduced by Lofti Zadeh in 1965 [16]. It uses
continuous set membership from 0 to 1, in contrast to Boolean
or conventional logic. Medicine is essentially a continuous
domain, and most medical data are inherently imprecise. We
chose a fuzzy logic algorithm because its successful use has
been reported in many applications, for instance to control
drug infusion to maintain adequate levels of anaesthesia, mus-
cle relaxation, arterial pressure control, and patient monitoring
and alarms [17]. In particular, fuzzy logic appears well suited
to medical decision making in the ICU [18].
The main aim of septic shock treatment is to restore and main-
tain adequate tissue oxygenation [19]. This can only be
achieved through appropriate control of the MAP and cardiac
index. Norepinephrine is the vasopressor currently used to
manage hypotension in patients with an optimal cardiac filling
pressure. The first haemodynamic effect observed with nore-
pinephrine is an increase in systemic vascular resistance and
consequently in MAP through stimulation of α-receptors. Addi-
tional stimulation of β-receptors increases the cardiac index
[20]. Vasopressors such as norepinephrine should be used
Figure 2
Kaplan-Meier curves demonstrating the probability of being on nore- pinephrine therapy during the study Kaplan-Meier curves demonstrating the probability of being on nore-
pinephrine therapy during the study. Comparisons between the time 
distribution of both groups were performed by means of the general-
ized Wicolxon (Breslow) test. Competitive risk analysis was performed 
when the occurrence of death interacted with the event under study 
(two patients); P < 0.0001.
Table 2
Outcome measures
Measure Control group (n = 20) Fuzzy group (n = 19) P
Shock duration (hours) 57.5 (43.7–117.5) 28.5 (20.5–42) <0.0001
Weaning failure (%) 2 (10) 0 (0) 0.49
Mortality at 28 days (%) 7 (37) 7 (35) 0.80
Mechanical ventilation (days) 20 (11–32) 15 (7–38) 0.96
ICU-free days at day 28 7 (0–18) 3 (0–17) 0.74
Total norepinephrine infuseda (μg/kg) 1.4 (0.6–2.7) 0.6 (0.2–1.0) <0.01
Crystalloid/colloida (ml) 8750 (6000–14000) 6000 (3275–7512) 0.47
Values are expressed as median (interquartile range). aTotal amount administered during shock. ICU, intensive care unit.Critical Care    Vol 12 No 6    Merouani et al.
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only to restore resistance and/or MAP values to normal in
patients with marked and documented vasodilatation [3].
The target MAP level is a value above 65 mmHg, which is per-
haps a little higher than should be sought in patients with cor-
onary risk factors [3,21]. We achieved and maintained this
target with norepinephrine doses that we considered near
optimal insofar as they were determined by a feedback system
controlled by fuzzy logic. The total amount of norpinephrine
administered was much reduced in the fuzzy group compared
with the control group, probably because the physiological
requirements for a drug with a very short half-life are better met
by sinusoidal variation in infusion rate. This resulted in a lower
total dose being administered and in an apparently shorter
duration of septic shock.
Another advantage of fuzzy logic based closed-loop control of
norepinephrine infusion was MAP during the weaning period.
As shown in Figure 3, the patient's MAP slowly oscillates
around the target value set by the intensivist in the fuzzy group;
this is in contrast to the control patient, in whom it tends to
drift, with more marked amplitudes. Nevertheless, the curve
analysis did not reveal any statistically significant differences
between the groups in terms of number of hypotensive epi-
sodes (defined as a MAP <55 mmHg; data not shown).
The rate of infusion rate modifications was empirically set at 7
minutes in order to take into account the equipment's inertia
and patient's time to haemodynamic response. We estimated,
during the study, the system's inertia by measuring the time
separating a norepinephrine rate infusion peak from a MAP
peak (see Figure 3). By using this method, we arrived at an
estimate of 15 minutes. We therefore believe that this rate
should be employed in further studies.
The shorter duration of shock may be due to a much reduced
vascular response to α-agonists during the early phase of sep-
tic shock [22]. Studies in vitro and in vivo have suggested that
α-adrenergic receptors (α1A, α1B and α1D) are downregu-
lated at the level of gene expression and that this effect is
mediated by proinflammatory cytokines [23]. Catecholamines,
and in particular norepinephrine, also downregulate α-adren-
ergic receptors [24]. Prolonged exposure of human embryonic
kidney cells to norepinephrine decreases the level of α1A-
Figure 3
Time dependence in norepinephrine infusion rate and mean arterial pressure Time dependence in norepinephrine infusion rate and mean arterial pressure. (a) Norepinephrine (NE) infusion rate and mean arterial pressure 
(MAP) over time for a representative patient included in the control group. There is a linear decrease in norepinephrine infusion rate. (b) Norepine-
phrine infusion rate and MAP over time for a representative patient included in the fuzzy group. The change in norepinephrine infusion rate is more or 
less sinusoidal.Available online http://ccforum.com/content/12/6/R155
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adrenergic receptor subunits at 48 hours by nearly 40% and
of α1D-receptors at 24 hours by 51%. Similar results have
been obtained in rabbit aortic smooth muscle cells. The
decrease is observed after 4 hours of exposure and gives way
to a gradual increase at 24 hours. It occurs in the wake of a
decrease in the level of α1-adrenergic receptor mRNA [24].
The closed-loop control based on a fuzzy logic algorithm, by
limiting exposure to norepinephrine, might preserve the func-
tion and pool of α1-receptor and thus lead to decreased
patient resistance to norepinephrine infusion.
Conclusion
We conclude that a closed-loop system based on fuzzy logic
algorithm results in the use of much lower norepinephrine
doses during weaning in patients with septic shock and leads
to a decrease in the duration of weaning duration. By providing
optimal delivery in relation to the individual patient's physiol-
ogy, fuzzy control might constitute a better approach than con-
stant flow infusion. Further studies in a larger number of
patients are needed to confirm these results and to assess the
effect of fuzzy control of norepinephrine infusion on morbidity
and mortality.
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